TargetMol

Fenspiride hydrochloride

Product Code:
 
TAR-T0383
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T0383-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0383-50mg50mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0383-100mg100mg£127.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0383-200mg200mg£149.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Fenspiride, an oxazolidinone spiro compound, is a drug used in the therapy of certain respiratory diseases. It is approved for use in Russia for the therapy of chronic and acute inflammatory diseases of ENT organs and the respiratory tract (like sinusitis, tracheobronchitis, otitis, laryngitis, and rhinopharyngitis), and for maintenance therapy of asthma.
CAS:
5053-08-7
Formula:
C15H21ClN2O2
Molecular Weight:
296.8
Pathway:
Neuroscience; Metabolism; Immunology/Inflammation; GPCR/G Protein
Purity:
0.9992
SMILES:
Cl.O=C1NCC2(CCN(CCc3ccccc3)CC2)O1
Target:
Adrenergic Receptor; PDE; Histamine Receptor

References

1. Cortijo J, et al. Eur J Pharmacol, 1998, 341(1), 79-86. 2. Cunha FQ, et al. Eur J Pharmacol, 1993, 238(1), 47-52. 3. Mattsson C, et al. Eur Arch Otorhinolaryngol, 1997, 254(9-10), 425-429. 4. De Castro CM, et al. Eur J Pharmacol, 1995, 294(2-3), 669-676.